The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points for faster myeloma approvals. Under this framework, MRD negativity is ...
Turning to the acquired business contribution, following today's expected close of the transaction, we expect the Biosciences ...
The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...
In children with stage 1 type 1 diabetes, high daily doses of oral insulin for 1 year do not halt progression to dysglycemia or clinical diabetes, nor do they affect insulin autoantibody levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results